Sympathetic Ablation for Ventricular Arrhythmias
ConditionVentricular Tachycardia (VT)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSymKardia
About this trial
Enrolled patients will undergo an acute procedure in which a catheter is inserted near the heart to ablate a sympathetic nerve, reducing signals that trigger ventricular arrhythmias.
Eligibility criteria
Qualifiers
Age 18 or older at the time of informed consent
Willing and capable of providing written informed consent
Implanted ICD or CRT-D
Recurrent VT leading to ICD therapy (ATP or shock)
Disqualifiers
Contraindication to percutaneous femoral arterial access
Heparin-induced thrombotic thrombocytopenia
Prior surgical sympathectomy
ECMO therapy in the past 30 days
Trial design
Treatments tested in this trial
- Central sympathetic nerve ablation
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov